search
Kobayashi Pharmaceutical
Trends
- 1Kobayashi Pharmaceutical weighs takeover offer worth over ¥500 billion●Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese maker at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer valued at more than ¥500 billion. The possible deal comes as the company continues to face fallout from the scandal, which damaged its reputation and finances.